Fri, June 8, 2012
Thu, June 7, 2012
Wed, June 6, 2012
Tue, June 5, 2012
Mon, June 4, 2012
Sat, June 2, 2012
Fri, June 1, 2012
Thu, May 31, 2012
Wed, May 30, 2012
Tue, May 29, 2012
Mon, May 28, 2012
Sun, May 27, 2012
Sat, May 26, 2012
Fri, May 25, 2012
[ Fri, May 25th 2012 ] - Market Wire
GenVec Reports Inducement Award
Thu, May 24, 2012

Conditions of Growth, Economic Analysis - Research Report on Mylan Inc. and CA, Inc.


//health-fitness.news-articles.net/content/2012/ .. sis-research-report-on-mylan-inc-and-ca-inc.html
Published in Health and Fitness on Thursday, May 31st 2012 at 6:12 GMT by Market Wire   Print publication without navigation


May 31, 2012 09:06 ET

Conditions of Growth, Economic Analysis - Research Report on Mylan Inc. and CA, Inc.

HONG KONG--(Marketwire - May 31, 2012) - Today, [ www.EquityLeader.com ] introduced research coverage of Mylan Inc. (NASDAQ: [ MYL ]) and CA, Inc. (NASDAQ: [ CA ]). Full research reports are available to readers at: [ www.EquityLeader.com/index.php?sm1=MYL&sm2=CA ].

With markets in correction mode, investors are looking to quantify an accurate model, weighing positives and negatives of the months ahead. Upcoming negative pressures include China's slowdown, the European recession, the end of the Fed's Operation Twist stimulus program, continued geopolitical risks, election uncertainty, and potential 2013 budget bombshell of tax hikes and spending cuts. Meanwhile, positive offsets are driven by central banks (particularly China) cutting rather than hiking rates, deceleration in fuel and food prices, increase in consumer sentiment and resulting retail sales, signs of improvement in housing sales and new strength in auto production schedules.

Despite the current situation, our team continues to identify high momentum situations with growth potential -- there remains strong opportunity within careful discretion.

Equity Leader has decided to cover Mylan Inc. for its current position within the healthcare industry. Mylan Inc. (Mylan) is a pharmaceutical company, which develops, licenses, manufactures, markets and distributes generic, branded generic and specialty pharmaceuticals. The Company operates a specialty business, which is focused on respiratory, allergy and psychiatric therapies. A copy of this report detailing Mylan Inc. (NASDAQ: [ MYL ]) is available at: [ www.EquityLeader.com/index.php?sm1=MYL ].

Equity Leader is also taking note of CA, Inc. for its changing role within the technology industry. CA, Inc. (CA) is an independent enterprise information technology (IT) management software and solutions company. CA develops and delivers software and services. The Company operates in three segments: mainframe solutions, enterprise solutions and services. To download free research on CA, Inc. (NASDAQ: [ CA ]) investors may visit: [ www.EquityLeader.com/index.php?sm2=CA ].

About Equity Leader
Whether you are a first time investor or seasoned market professional, Equity Leader provides the resources necessary to simplify your research process. Our focus has always been to empower investors with the information they need to make their own investment decisions.



Publication Contributing Sources